| Q35980738 | ATP binding cassette transporter G1 deletion induces IL-17-dependent dysregulation of pulmonary adaptive immunity. |
| Q34065631 | ATP-binding cassette transporter G1 deficiency dysregulates host defense in the lung |
| Q33985943 | Anti-inflammatory effect of fluvastatin on IL-8 production induced by Pseudomonas aeruginosa and Aspergillus fumigatus antigens in cystic fibrosis |
| Q42220049 | Atorvastatin as a stable treatment in bronchiectasis: a randomised controlled trial. |
| Q58995173 | Continuation or Discontinuation of Statin Therapy Did Not Influence Patient Outcomes after the Development of Acute Respiratory Distress Syndrome |
| Q42326095 | Differential effects of simvastatin on IL-13-induced cytokine gene expression in primary mouse tracheal epithelial cells |
| Q35616009 | Dual role for RhoA in suppression and induction of cytokines in the human neutrophil |
| Q37979794 | Dysregulated inflammation as a risk factor for pneumonia in the elderly |
| Q37710193 | Effect of Prior Atorvastatin Treatment on the Frequency of Hospital Acquired Pneumonia and Evolution of Biomarkers in Patients with Acute Ischemic Stroke: A Multicenter Prospective Study. |
| Q56952861 | Effect of statins on outcomes in immunosuppressed patients with bloodstream infection |
| Q37667279 | Effects of atorvastatin on smoking-induced alveolar injury in rat lungs |
| Q36724871 | Effects of liver X receptor agonist treatment on pulmonary inflammation and host defense. |
| Q36303634 | Emerging roles for cholesterol and lipoproteins in lung disease |
| Q36956158 | Endothelial cell barrier protection by simvastatin: GTPase regulation and NADPH oxidase inhibition |
| Q44506811 | Endotoxin-induced cardiovascular dysfunction in mice: effect of simvastatin |
| Q39607310 | Gene expression profiles of RAW264.7 macrophages stimulated with preparations of LPS differing in isolation and purity |
| Q34611737 | Human models of acute lung injury. |
| Q34269660 | Impact of oral simvastatin therapy on acute lung injury in mice during pneumococcal pneumonia |
| Q28570741 | Induction of CXCL5 during inflammation in the rodent lung involves activation of alveolar epithelium |
| Q35679301 | Lovastatin decreases acute mucosal inflammation via 15-epi-lipoxin A4. |
| Q89510732 | Lung Macrophage Functional Properties in Chronic Obstructive Pulmonary Disease |
| Q42177559 | Mechanisms of action and efficacy of statins against influenza. |
| Q34026316 | Mechanisms of neutrophil accumulation in the lungs against bacteria |
| Q37606170 | Novel relationship of serum cholesterol with asthma and wheeze in the United States. |
| Q28246595 | Pandemic influenza: a potential role for statins in treatment and prophylaxis |
| Q36551235 | Potential therapeutic role for statins in respiratory disease |
| Q44684592 | Protective effect of pravastatin on lipopolysaccharide-induced acute lung injury during neutropenia recovery in mice |
| Q43725353 | Reduced risk of poststroke pneumonia in thrombolyzed stroke patients with continued statin treatment |
| Q37267573 | Renal and liver tumors in Tsc2(+/-) mice, a model of tuberous sclerosis complex, do not respond to treatment with atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor |
| Q40835741 | Roles of the Mevalonate Pathway and Cholesterol Trafficking in Pulmonary Host Defense. |
| Q36421706 | STAT1-regulated lung MDSC-like cells produce IL-10 and efferocytose apoptotic neutrophils with relevance in resolution of bacterial pneumonia |
| Q36243216 | Simvastatin Suppresses Airway IL-17 and Upregulates IL-10 in Patients With Stable COPD. |
| Q43246207 | Simvastatin as a potential therapeutic for acute respiratory distress syndrome |
| Q37225099 | Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers |
| Q34840907 | Simvastatin decreases the level of heparin-binding protein in patients with acute lung injury. |
| Q37423130 | Simvastatin inhibits airway hyperreactivity: implications for the mevalonate pathway and beyond |
| Q39514476 | Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy. |
| Q41274980 | Simvastatin modulates cellular components in influenza A virus-infected cells. |
| Q41429627 | Simvastatin protects against cholestasis-induced liver injury |
| Q34305806 | Simvastatin reduces endotoxin-induced acute lung injury by decreasing neutrophil recruitment and radical formation |
| Q36571988 | State of the art. Apoptosis and cell homeostasis in chronic obstructive pulmonary disease |
| Q36237936 | Statin treatment and reduced risk of pneumonia in patients with diabetes |
| Q37229844 | Statin use and risk of community acquired pneumonia in older people: population based case-control study |
| Q42572130 | Statin use reduces decline in lung function: VA Normative Aging Study |
| Q37956128 | Statins and associated risk of pneumonia: a systematic review and meta-analysis of observational studies |
| Q34086279 | Statins and prevention of infections: systematic review and meta-analysis of data from large randomised placebo controlled trials |
| Q42991831 | Statins as a novel therapeutic strategy in acute lung injury |
| Q37754865 | Statins as emerging treatments for asthma and chronic obstructive pulmonary disease |
| Q41426439 | Statins enhance formation of phagocyte extracellular traps |
| Q37639928 | Statins for community-acquired pneumonia: current state of the science. |
| Q36369699 | Statins in the critically ill |
| Q79398950 | Statins inhibit lymphocyte homing to peripheral lymph nodes |
| Q59349662 | Statins: a viable candidate for host-directed therapy against infectious diseases |
| Q35025114 | The Acute Respiratory Distress Syndrome: Pathogenesis and Treatment |
| Q49791943 | Treatment with atorvastatin provides additional benefits to imipenem in a model of Gram-negative pneumonia induced by Klebsiella pneumoniae in mice |
| Q36442993 | Update in critical care 2005. |
| Q36457183 | Update in environmental and occupational medicine 2005. |
| Q37965356 | Year in review 2010: Critical Care--Respirology |
Search more.